LESLIE DORK: Open Payments
NPI 1790703361 · ALBUQUERQUE, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,427 in 25 payments from 10 companies in 2025. Trend: 2023 $1,204 · 2024 $873 · 2025 $1,427
Food & beverage: $1,427
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $341 |
| Amgen Inc. | 6 | $336 |
| NxStage Medical, Inc. | 3 | $231 |
| Vifor Pharma, Inc. | 4 | $153 |
| AKEBIA THERAPEUTICS INC | 1 | $111 |
| Novo Nordisk Inc | 2 | $88 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $78 |
| Mozarc Medical US LLC | 3 | $50 |
| Fresenius USA Marketing, Inc. | 1 | $21 |
| SHIELD THERAPEUTICS INC | 1 | $17 |
Products named: KRYSTEXXA, Veltassa, NXSTAGE SYSTEM ONE, FARXIGA, LOKELMA, TAVNEOS, Vafseo, LIBERTY SELECT CYCLER.
Industry payments across NM — which companies pay providers there.
